HIV can currently be managed effectively so long as patients conform to a regime of regular antiretrovirals (ARVs). The treatment means that people with HIV can live a normal duration of life so long as they take daily drugs, although if they stop doing so the viral level rapidly increases and starts once again attacking their immune system.
However, a new piece of research suggests that this may not always have to be the case. In fact, the vaccine-based therapy currently being trialed among 13 HIV-active participants resulted in five patients being able to keep a retain a low, non-dangerous viral load — despite one of them not having taken ARVs for 27 weeks. The others were virus free for five, 13, 17, and 20 weeks after stopping taking their regularly scheduled medication.
More: Scientists managed to ‘cut out’ HIV virus from rats
“It is a proof of concept that with vaccines we might …